Back to Search Start Over

Beta4 integrin promotes osteosarcoma metastasis and interacts with ezrin.

Authors :
Wan, X.
Kim, S. Y.
Guenther, L. M.
Mendoza, A.
Briggs, J.
Yeung, C.
Currier, D.
Zhang, H.
Mackall, C.
Li, W.-J.
Tuan, R. S.
Deyrup, A. T.
Khanna, C.
Helman, L.
Source :
Oncogene. 9/24/2009, Vol. 28 Issue 38, p3401-3411. 11p. 6 Graphs.
Publication Year :
2009

Abstract

The development of pulmonary metastasis is the major cause of death in osteosarcoma, and its molecular basis is poorly understood. In this study, we show that β4 integrin is highly expressed in human osteosarcoma cell lines and tumor samples. Furthermore, highly metastatic MNNG-HOS cells have increased levels of β4 integrin. Suppression of β4 integrin expression by shRNA and disruption of β4 integrin function by transfection of dominant-negative β4 integrin was sufficient to revert this highly metastatic phenotype in the MNNG-HOS model without significantly affecting primary tumor growth. These findings suggest a role for β4 integrin expression in the metastatic phenotype in human osteosarcoma cells. In addition, we identified a previously uncharacterized interaction between β4 integrin and ezrin, a membrane-cytoskeletal linker protein that is implicated in the metastatic behavior of osteosarcoma. The β4 integrin–ezrin interaction appears to be critical for maintenance of β4 integrin expression. These data begin to integrate ezrin and β4 integrin expression into a model of action for the mechanism of osteosarcoma metastases. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
09509232
Volume :
28
Issue :
38
Database :
Academic Search Index
Journal :
Oncogene
Publication Type :
Academic Journal
Accession number :
44295555
Full Text :
https://doi.org/10.1038/onc.2009.206